Insider Shareholders with Direct Ownership of G1 Therapeutics, Inc. (GTHX)
This section provides a comprehensive overview of the insiders with direct ownership of G1 Therapeutics, Inc. (GTHX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
G1 Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
465,040 | 386,040 | 116,000 $829,400 | 53 |
Aug 08, 2023
Reduced 2.29%
|
|
50,633 | 3,813 | 57,820 $413,413 | 8 |
Jan 05, 2023
Reduced 1.25%
|
|
James S. Hanson
General Counsel |
40,900 | 3,813 | 41,087 $293,772 | 6 |
Jan 05, 2023
Reduced 1.74%
|
14,389 | 0 | 14,389 $102,881 | 2 |
Jun 23, 2022
Added 41.0%
|
|
Soma Gupta
Chief Commercial Officer |
11,000 | 0 | 11,000 $78,650 | 1 |
Jan 04, 2021
Added 50.0%
|
14,389 | 10,000 | 4,389 $31,381 | 3 |
Jun 29, 2021
Reduced 69.5%
|
|
34,389 | 34,389 | 0 $0 | 5 |
Sep 18, 2024
Reduced 100.0%
|
|
Rajesh Malik
Chief Medical Officer |
317,639 | 346,839 | 0 $0 | 36 |
Sep 18, 2024
Reduced 100.0%
|
Terry L Murdock
Chief Operating Officer |
166,100 | 166,100 | 0 $0 | 17 |
Sep 18, 2024
Reduced 100.0%
|
20,000 | 20,000 | 0 $0 | 3 |
Sep 18, 2024
Reduced 100.0%
|
|
84,389 | 205,358 | 0 $0 | 6 |
Sep 18, 2024
Reduced 100.0%
|
|
John E. (Jack) Bailey Jr.
President and CEO |
895,133 | 895,133 | 0 $0 | 18 |
Sep 18, 2024
Reduced 100.0%
|
Mark Avagliano
Chief Business Officer |
278,960 | 278,960 | 0 $0 | 14 |
Sep 18, 2024
Reduced 100.0%
|
34,389 | 35,889 | 0 $0 | 5 |
Sep 18, 2024
Reduced 100.0%
|
|
30,000 | 30,000 | 0 $0 | 4 |
Sep 18, 2024
Reduced 100.0%
|
|
Andrew Perry
Chief Commercial Officer |
141,770 | 141,790 | 0 $0 | 12 |
Sep 18, 2024
Reduced 100.0%
|
20,000 | 20,000 | 0 $0 | 3 |
Sep 18, 2024
Reduced 100.0%
|
|
John V. Umstead
Chief Financial Officer |
194,800 | 203,686 | 0 $0 | 11 |
Sep 18, 2024
Reduced 100.0%
|
Monica R. Thomas
Chief Legal & People Officer |
150,475 | 150,651 | 0 $0 | 6 |
Sep 18, 2024
Reduced 100.0%
|